Member Info for chrishutch

Https://x.com/InvestorMeetCo/status/1709478565446565899?s=20

I am confident.

Easy mate but I wanted twice that very least. I want 15-22p

Madness this price, they have worked for eight of the top 10 global pharmaceutical companies by revenue. It is a matter of time before a big contract lands and all those watching it from the sidelines will miss the opportunity.

🐤FAB mcap is £3.4m and the company currently has c.£1m in cash.

🐤So its EV is in the region of £2.4m. Which is way too cheap!

🐤In my view, the company is a much better run entity now. It has some work to do but this share price is a real gift.

🐤It is in the final stages of a second Ai partnership and has already seen and stated that in the past few months, the Company has enjoyed an uplift in business & purchase orders have been received.

🐤A three fold uplift since the start of 2023, it really could be one of those companies that injects a lot of profit into retail hands.

🐤Interview tomorrow too.

🐤If you are on the sidelines I would take a starter now.

The company previously said they have the cash to reach profitability, the research note said 15 months cash.

They also said that when you factor the cash into the mcap that (actually rather than me word it I will just quote).

: Fusion’s market capitalisation is £3.4m and the company currently has c.£1m in

cash, so its EV is in the region of £2.4m. While we acknowledge that the company has to

succeed in its turnaround to regain shareholder support, we consider that this figure does

not to ascribe any value to Fusion’s potentially valuable and class-leading technologies,

that could be worth a multiple of this figure.

Not my figure it is in the research note mate

15 month casy runway

final stages of second AI conmpany

Focus on AI partnerships: A new strategy has put the focus on the integrated service

offering and striking partnerships with AI companies, capitalising on the opportunity to link

up with specialist AI companies that need to add lab-based validation as an integrated

design and test service.

Fusion has executed the first of what it hopes will be a number of

these and is in the final stages of negotiation with a second such company.

FAB Fusion now has cash of around £1m, giving it a cash runway in excess of 15 months on its reduced cost base.

I took a few more today.

https://www.linkedin.com/posts/fusion-antibodies-plc_today-we-welcome-simon-l****n-to-the-fusion-activity-7114670385836515330-kyeh?utm_source=share&utm_medium=member_ios

Rns not end

Not sure about a Boston end so soon but it sounds like connections were made. I think we might see a couple of rns coming our way, new staff member and start of new project closer to home, tho.

As a few have asked questions in the telegram group I thought I could share some direct quotes from the results here that might help those that see the document as bit too large to bother with

1. "As previously mentioned, in June 2023 the Company issued equity for net proceeds of c.£1.5m which puts it in a good position to continue its sales and marketing activities and the development of new discovery platforms and services. "

2) In the past few months, the Company has enjoyed an uplift in business engagement from lead generation through to quote drafting and, pleasingly, purchase orders received. We've seen a strengthening of the pipeline of approximately three-fold since the end of 2023. As a result, revenues for FY2024 will be significantly weighted towards the second half of the year.

3) and are in a good cash position and have some exciting and enviable discovery services in development.

Bought 70k more so far

Would be fab haha

Now that is out the way lets see the recovery start and positive newsfow

We got this.

Come on FAB lets say good bye to the 6s once and for all.

What do we think 8p by close?